Etanidazole (SR-2508) is a 2-nitroimidazole drug with radiosensitizing properties. Etanidazole depletes glutathione and inhibits glutathione transferase, thereby enhancing the cytotoxicity of ionizing radiation. This agent may also be useful as an imaging agent for identifying hypoxic, drug-resistant regions of primary tumors or metastases. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). References: Yang Y, Jin C, Li H, He Y, Liu Z, Bai L, Dou K. Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo. Exp Ther Med. 2012 Feb;3(2):299-303. Epub 2011 Nov 24. PubMed PMID: 22969885; PubMed Central PMCID: PMC3438662.

纯度：≥98%

CAS：22668-01-5